Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors in Lipid Metabolism and Atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology - United States
doi 10.1161/01.atv.0000015598.86369.04
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Peroxisome Proliferator-Activated Receptors in Atherosclerosis and Inflammation—An Update

Toxicologic Pathology
Forensic MedicineToxicologyPathologyCell BiologyMolecular Biology
2001English

Drugs and the Peroxisome Proliferator Activated Receptors

2014English

Peroxisome Proliferator-Activated Receptors and Hepatitis C Virus

Therapeutic Advances in Gastroenterology
Gastroenterology
2011English

Peroxisome Proliferator-Activated Receptors in HCV-Related Infection

PPAR Research
Drug DiscoveryPharmacology
2009English

Peroxisome Proliferator-Activated Receptors (Ppars) in Health and Disease.

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
BiochemistryMedicineGeneticsMolecular Biology
2002English

The Metabolic Syndrome: Relationship Between Insulin Sensitivity and the Role of Peroxisome Proliferator-Activated Receptors (Ppars) in Saccharide and Lipid Metabolism

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
BiochemistryMedicineGeneticsMolecular Biology
2005English

Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in Asthma

PPAR Research
Drug DiscoveryPharmacology
2020English

Peroxisome Proliferator-Activated Receptors - Alpha in Chronic Inflammation - Mini-Review

International Journal of Pharmacology, Phytochemistry and Ethnomedicine
2019English

Emerging Role of the Peroxisome Proliferator-Activated Receptors in Hepatocellular Carcinoma

Journal of Carcinogenesis & Mutagenesis
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy